IPCI - IntelliPharmaCeutics International Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue11/30/201711/30/201611/30/2015
Total Revenue5,504.4522,247.0024,093.781
Cost of Revenue704.006--
Gross Profit4,800.4462,247.0024,093.781
Operating Expenses
Research Development9,271.3538,166.7367,247.473
Selling General and Administrative3,287.9143,546.1323,581.913
Non Recurring---
Others506.961385.21377.849
Total Operating Expenses---
Operating Income or Loss-8,265.782-9,851.076-7,113.454
Income from Continuing Operations
Total Other Income/Expenses Net-202.419-22.263-66.305
Earnings Before Interest and Taxes-8,468.201-9,873.339-7,179.759
Interest Expense389.239270.238256.629
Income Before Tax-8,857.44-10,143.577-7,436.388
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-8,857.44-10,143.577-7,436.388
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-8,857.44-10,143.577-7,436.388
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-8,857.44-10,143.577-7,436.388